About Adamed
About Adamed
Adamed in Poland
Adamed across the globe
Supervisory Board of Adamed Pharma S.A.
Management Team of Adamed Pharma S.A.
Mission and values
Ethics and Compliance
Adamed for the Family
News
Adamed is a pharmaceutical and biotechnology company with 40 years of experience, founded on the basis of Polish scientific advances and a patent portfolio.
Products
Produkty
Prescription drugs
OTC drugs
Dietary supplements
Dermocosmetics
Medical devices
We provide patients with the highest quality medicinal products that are a response to chronic civilization diseases in several therapeutic areas.
Development and innovation
Development and innovation
Research
Development of proprietary medicines
Development of value-added medicines
Business development Startups Requests for proposals and tenders
Innovation is at the core of Adamed’s evolution. It allows us to pursue our mission by responding to the key challenges of modern medicine.
ESG
CSR
Adamed Foundation
Social programmes
Code of Ethics
Responsibility is one of our key values. It is at the core of everything we do and has earned us the trust of patients and the medical community.
Career
Career
Benefits
Development
Locations
Internships and apprenticeships
People are a priority at Adamed, and their passion and dedication has helped us grow into a successful company. Recognising the value of our staff, we are committed to providing excellent work conditions and career opportunities.
Contact

Global English

Popular searches Innovations About Adamed Business Development Adamed worldwide Researches

x

Information on the resultus of the Procurement Procedure under Request for Proposal RFP - 260915 - DEVELOPMENT WORK RELATED TO A MULTI-DOSE BLISTER-TYPE DRY POWDER INHALER

In connection with the implementation of the following projects:

Project “Development, Clinical Confirmation of Bioequivalence and Implementation of a Next-Generation Triple-Combination Inhalation Medicinal Product for Maintenance Treatment of COPD”, Grant Agreement No. 2022/ABM/04/00011-00
Project “Development, Clinical Confirmation of Bioequivalence and Implementation of a Next-Generation Combination Inhalation Medicinal Product for Maintenance Treatment of COPD”, Grant Agreement No. 2022/ABM/04/00012-00
Project “Development, Clinical Confirmation of Bioequivalence and Implementation of a Next-Generation Combination Inhalation Medicinal Product for Maintenance Treatment of Respiratory Diseases, Including Asthma and COPD”, Grant Agreement No. 2022/ABM/04/00013-00

funded from the state budget by the Medical Research Agency (Agencja Badań Medycznych) under the Competition for the Development and Advancement of Innovative Solutions in the Field of New Pharmaceutical Forms of Authorized Medicinal Products, Generic Medicines and Biosimilar Medicines (ABM/2022/4), and acting pursuant to § 8(2)(2) of the Grant Agreement, Adamed Pharma S.A. hereby informs that, in accordance with the provisions of the Request for Proposal, the contract will be awarded to Pulinno Sp. z o.o.